CHTP Practice Test

Certifications > CHTP > Practice Test

CHTP Practice Test (V1)

Dive into practice questions

Question 1

A 52-year-old postmenopausal woman with an intact uterus is experiencing severe vasomotor symptoms. She has no contraindications to menopausal hormone therapy (MHT). Which therapeutic regimen is most appropriate to initiate?

  1. Transdermal estradiol patch, used alone.
  2. Oral conjugated equine estrogens, used alone.
  3. Oral micronized progesterone, used alone.
  4. Transdermal estradiol patch combined with cyclic oral micronized progesterone.

Question 2

A patient on a stable dose of transdermal estradiol cream reports that her symptoms of vaginal dryness have resolved, but she is now experiencing breast tenderness and fluid retention. What is the most likely cause of these new symptoms?

  1. The patient is having an allergic reaction to an inactive ingredient in the cream.
  2. The patient is experiencing systemic side effects due to excessive estrogen absorption.
  3. The patient has developed a progesterone deficiency that was masked previously.
  4. These symptoms are unrelated to the hormone therapy and require a separate medical workup.

Question 3

A CHTP is counseling a patient about bioidentical hormone replacement therapy (BHRT) from a compounding pharmacy. Which statement is the most accurate and compliant piece of information to provide the patient?

  1. "Compounded BHRT is safer than FDA-approved products because it is all-natural and made just for you."
  2. "These custom-made hormones are not reviewed by the FDA for safety or efficacy, and their dose consistency can vary between batches."
  3. "You will not experience any side effects with compounded BHRT, unlike with the commercial products."
  4. "Insurance companies prefer compounded BHRT because it is less expensive than manufactured hormone products."

Question 4

Which absolute contraindication would prevent a pharmacist from recommending the initiation of systemic estrogen-containing hormone therapy for a symptomatic perimenopausal patient?

  1. A personal history of migraine headaches with aura.
  2. A family history of breast cancer in a maternal aunt.
  3. Current, unexplained vaginal bleeding.
  4. A well-controlled hypertension diagnosis.

Answer Key

  • Question 1: D. Transdermal estradiol patch combined with cyclic oral micronized progesterone. (Systemic estrogen is needed for vasomotor symptoms, and a progestogen is required for endometrial protection in a woman with a uterus.)
  • Question 2: B. The patient is experiencing systemic side effects due to excessive estrogen absorption. (These are classic symptoms of estrogen excess. Even topical therapies can have systemic absorption.)
  • Question 3: B. "These custom-made hormones are not reviewed by the FDA for safety or efficacy, and their dose consistency can vary between batches." (This is an accurate, neutral statement regarding the regulatory status and potential risks of compounded preparations.)
  • Question 4: C. Current, unexplained vaginal bleeding. (This is an absolute contraindication, as it must be investigated to rule out endometrial cancer before initiating estrogen therapy.)